Delivery Order SPE2DB20D1109-SPE2DB25FP45V
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,078.44 to AmerisourceBergen Drug Corp for Belbuca 150 mcg film (60 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) represents a routine pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BELBUCA 450 MCG Film in a quantity of 60 units, with a ceiling value of $1,053.12. This firm fixed price contract, awarded on July 23, 2025, represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $2,043.16 on July 28, 2025, with completion targeted for July 29, 2025. This contract represents a firm fixed price delivery order for BELBUCA 150 MCG Film 60S, a pharmaceutical product, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $4,370.61 to AmerisourceBergen Drug Corp for the supply of Belbuca 600 MCG film (60 count), a pharmaceutical product used in pain management. This contract is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.43 to AmerisourceBergen Drug Corp for Belbuca 300 mcg film (60 count) on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which is not set aside, represents a pharmaceutical supply delivery under the company's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This is a $1,000.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BELBUCA 900 MCG FILM 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,023.86 firm fixed-price contract is for the supply of BELBUCA 600 MCG FILM 60S, a prescription medication. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive...
- This is a $1,808.38 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELBUCA 300 MCG FILM 60S, a pain management pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of July 8, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,035.01, is for the supply of Belbuca 150 MCG film, a medication used for pain management. The contract has an ultimate completion date of May 28, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP45VDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,061.52 to AmerisourceBergen Drug Corp for BELBUCA 300 MCG Film (60 count) on July 25, 2025, with completion expected by July 28, 2025. This is a firm fixed price, non-set-aside contract executed as a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product is a buccal film formulation used for pain management, reflecting the company's role as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The work is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents one transaction within AmerisourceBergen's expansive pharmaceutical supply portfolio with the Defense Logistics Agency. The contractor holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical through December 2026, which serves as the overarching vehicle enabling flexible procurement of brand-name and generic pharmaceuticals, vaccines, and medical supplies to support military healthcare operations globally. AmerisourceBergen's consistent success in securing competitive federal awards across diverse therapeutic categories demonstrates its capability to meet complex medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/25/25 |